Table 1 Worldwide prevalence of Parkinson’s disease
From: Is insulin-like growth factor-1 involved in Parkinson’s disease development?
Country | General population | References |
|---|---|---|
High SDI countries | 2.1 million (34.4%) | [3] |
High-middle or middle SDI countries | 3.1 million (50.8%) | |
Low SDI countries | 0.9 million (14.8%) | |
Worldwide | 6.1 million Female: 2.9 million (47.5%) Male: 3.2 million (52.5%) |